Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/30/18 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
27 | |
| 04/26/18 | 8-K | Current report filing |
|
4 | |
| 04/03/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/30/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
90 |
| 03/28/18 | 8-K | Current report filing |
|
11 | |
| 03/20/18 | 8-K | Current report filing |
|
3 | |
| 03/06/18 | 8-K | Current report filing |
|
30 | |
| 02/13/18 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
8 | |
| 12/21/17 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/19/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
